Drug and Therapeutics Bulletin 2005;43:9-12; doi:10.1136/dtb.2005.4329
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Opioid analgesics for cancer pain in primary care

Relevant BNF section: 4.7.2

Each year, around 140,000 people die from cancer in England and Wales,1 about one-quarter of them in the community.2 Two crucial goals in the palliative care of such people are to enhance quality of life and control symptoms. Of particular importance, more than two-thirds of patients with cancer will require opioid analgesics to control pain.3 Since many patients with cancer, including those with advanced disease, aim to spend more time at home rather than in hospital, the primary care team has an important role in managing pain. The team, supported by community clinical nurse specialists and specialist palliative care units, is often responsible for initiating analgesic therapy and for ongoing assessment of patients' pain and analgesic requirements. Here we discuss key issues in using opioids for cancer-related pain in primary care.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 2005 BMJ Publishing Group Ltd.